Clinical Trial Update: Calcium Hydroxide, Mineral Trioxide Aggregate and Biodentine (Trademark) as Direct Pulp Capping of Permanent Teeth [Phase 2, Phase 3]

View source ↗

Summary

Phase 2 and 3 clinical trial evaluating calcium hydroxide, mineral trioxide aggregate, and Biodentine as direct pulp capping materials in permanent teeth with c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dental Caries
• Pulpitis

Drugs mentioned

• Biodentine (tricalcium silicate cement)
• Calcium hydroxide (calcium hydroxide)
• Mineral Trioxide Aggregate (mineral trioxide aggregate)

Snippet

Sponsor: Universidad de los Andes, Chile | Conditions: Caries, Dental Pulp Exposure | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2017-08-14